Haemonetics Q1 Adj $1.02 Beats $1.01 Estimate, Sales $336.17M Beat $335.38M Estimate

Author: Benzinga Newsdesk | August 08, 2024 06:06am
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $1.00 by 2 percent. This is a 2.86 percent decrease over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $336.17 million which beat the analyst consensus estimate of $335.38 million by 0.24 percent. This is a 7.98 percent increase over sales of $311.33 million the same period last year.

Posted In: HAE